JP2023521330A5 - - Google Patents

Info

Publication number
JP2023521330A5
JP2023521330A5 JP2022561019A JP2022561019A JP2023521330A5 JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5 JP 2022561019 A JP2022561019 A JP 2022561019A JP 2022561019 A JP2022561019 A JP 2022561019A JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
receptor
flbr
tnfr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022561019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521330A (ja
JP7755597B2 (ja
Filing date
Publication date
Priority claimed from GBGB2005331.0A external-priority patent/GB202005331D0/en
Priority claimed from GBGB2017358.9A external-priority patent/GB202017358D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/050866 external-priority patent/WO2021205176A2/en
Publication of JP2023521330A publication Critical patent/JP2023521330A/ja
Publication of JP2023521330A5 publication Critical patent/JP2023521330A5/ja
Priority to JP2025138496A priority Critical patent/JP2025170345A/ja
Application granted granted Critical
Publication of JP7755597B2 publication Critical patent/JP7755597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561019A 2020-04-09 2021-04-08 細胞 Active JP7755597B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138496A JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2005331.0 2020-04-09
GBGB2005331.0A GB202005331D0 (en) 2020-04-09 2020-04-09 Cell
GBGB2017358.9A GB202017358D0 (en) 2020-11-02 2020-11-02 Cell
GB2017358.9 2020-11-02
PCT/GB2021/050866 WO2021205176A2 (en) 2020-04-09 2021-04-08 Cell

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138496A Division JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Publications (3)

Publication Number Publication Date
JP2023521330A JP2023521330A (ja) 2023-05-24
JP2023521330A5 true JP2023521330A5 (https=) 2024-02-09
JP7755597B2 JP7755597B2 (ja) 2025-10-16

Family

ID=75539696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022561019A Active JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Country Status (7)

Country Link
US (1) US20230113183A1 (https=)
EP (1) EP4132963A2 (https=)
JP (2) JP7755597B2 (https=)
CN (1) CN115315439A (https=)
AU (1) AU2021253759A1 (https=)
CA (1) CA3174812A1 (https=)
WO (1) WO2021205176A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720949D0 (en) 2017-12-15 2018-01-31 Autolus Ltd Cell
JP2024541501A (ja) * 2021-11-25 2024-11-08 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ Ｃｄ９５ポリペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000063374A1 (en) 1999-04-16 2000-10-26 Celltech Therapeutics Limited Synthetic transmembrane components
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
US9931386B2 (en) * 2008-06-16 2018-04-03 Atsuo Ochi Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
EP4406604A3 (en) * 2015-03-05 2024-10-23 Fred Hutchinson Cancer Center Immunomodulatory fusion proteins and uses thereof
EP3569244A1 (en) * 2015-09-23 2019-11-20 CytoImmune Therapeutics, LLC Flt3 directed car cells for immunotherapy
CN119409836A (zh) 2017-03-17 2025-02-11 弗雷德哈钦森癌症中心 免疫调节融合蛋白及其用途
GB201716728D0 (en) * 2017-10-12 2017-11-29 Autolus Ltd Cell
GB201720949D0 (en) * 2017-12-15 2018-01-31 Autolus Ltd Cell
WO2019243817A1 (en) * 2018-06-19 2019-12-26 Autolus Limited Cell
CN113166226B (zh) * 2018-09-28 2025-06-27 纪念斯隆-凯特琳癌症中心 表达显性负性fas的免疫应答细胞及其用途

Similar Documents

Publication Publication Date Title
US12509499B2 (en) Therapeutic agents
JP2022130485A5 (https=)
JP6632073B2 (ja) キメラ抗原受容体
AU2024205827A1 (en) Expression of novel cell tags
JP2023513502A (ja) コロナウイルスワクチン
RU2020109577A (ru) Клетка
JP2021502070A5 (https=)
JP2023521330A5 (https=)
JP2025060882A5 (https=)
JP2017537627A5 (https=)
JP2021522790A5 (https=)
CN109072195A (zh) 具有增强功效的免疫效应细胞疗法
JP2022535005A5 (https=)
CN106573989A (zh) 信号传导系统
JP2018523484A (ja) 細胞
JP2019535262A5 (https=)
JP2021506275A5 (https=)
JP2021526795A5 (https=)
JP2025170345A5 (https=)
AU2018383084A1 (en) Cell
CA3206936A1 (en) Epigenetic gene regulation to treat neurological diseases and pain
US20220160870A1 (en) Neoantigen engineering using splice modulating compounds
TW202430551A (zh) 多發性骨髓瘤之bcma靶向car-t細胞療法
US20250302959A1 (en) Artificial immune receptors
JP2023548555A5 (https=)